NANOVATE

Biotechnological gene therapy, nucleic acid drug and protein delivery platform technology for loading, targeting, and enhancing secretomes, extracellular vesicles (EVs) and exosomes across gene therapy, RNA medicine, and protein therapeutics

Design, development and operation of gene therapy, nucleic acid drug and protein delivery platform technology for scientific and medical research and development to help pharmaceutical companies deliver proteins, antibodies, small molecule inhibitors, nucleic acid medicines, vaccines, gene silencing and gene editing